Protalix (PLX) Q3 2026 Earnings Call Transcript
· aol.com · popularity 51/100 · 63 similar stories today · Corporate News & M&A (Business & Finance)
Read the original at aol.com →
Summary
Tuesday, Nov. 10, 2026 CALL PARTICIPANTS Need a quote from a Motley Fool analyst? Email pr@fool.com Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) reported three-month revenue of $21.9 million and reaffirmed its full-year 2026 revenue guidance of $78.0 million to $83.0 million. Management stated that …
Found in: Machine Learning. Rating basis: 63 other outlets; outlet tier 2 (unlisted); 1 feeds; feed position 1.